Non-cytotoxic protection by human NK cells in mucosal secondary lymphoid tissues (Q37315683)

19 August 2017

1 reference

title

Non-cytotoxic protection by human NK cells in mucosal secondary lymphoid tissues (English)

1 reference

19 August 2017

0 references

Christian Münz

1

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

European Journal of Immunology

19 August 2017

published in

1 reference

19 August 2017

volume

38

1 reference

19 August 2017

issue

11

1 reference

19 August 2017

page(s)

2946-2948

1 reference

The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

NK cell compartments and their activation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

What does it take to make a natural killer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Distribution of lymphocyte subsets and natural killer cells in the human body

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Number and distribution of lymphocytes in man. A critical analysis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Reciprocal activating interaction between natural killer cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Dendritic cells prime natural killer cells by trans-presenting interleukin 15

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

NK cells interactions with dendritic cells shape innate and adaptive immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Natural killer cell behavior in lymph nodes revealed by static and real-time imaging.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

The biology of human natural killer-cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838849

7 January 2021

Identifiers

DOI

10.1002/EJI.200838849

1 reference

19 August 2017

1 reference